UPL shares surged 5% to Rs 636.45 on strong Q3 results, driven by agrochemical demand recovery. Investec upgraded UPL to buy with a Rs 700 target, while Nuvama raised its target to Rs 705. Management expects 50% YoY EBITDA growth, citing margin recovery, debt reduction, and improved business conditions.
Vedanta demerger can create value in the long term
Vedanta’s stock has seen a dip following the announcement of its demerger into five listed entities, aimed at reducing the conglomerate discount. Investors looking to